A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson University.
Full article >>
Thursday, June 4, 2009
Researchers identify critical marker of response to gemcitabine in pancreatic cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment